AI toxicity platform Target small biotech and specialty chemical companies that need real-time, AI-driven toxicity assessment across vast chemical inventories, highlighting ViridisChem’s 90 million chemical database and 2.5 billion properties to accelerate safety evaluations.

Regulatory edge Position to regulatory-focused teams by emphasizing access to global regulatory lists and full GHS classification within the platform, enabling faster SDS development and compliance-ready outputs for customers with complex supply chains.

Strategic partnerships Leverage existing partnerships in Korea and Tokyo as a blueprint to co-sell with distributors and regional pharma/chemical networks, expanding reach to potential customers in Asia-Pacific and associated markets.

Cost-efficient tooling Highlight the potential for cost savings and risk reduction for early-stage biotech startups and CROs through real-time toxicity modeling and multi-endpoint predictions, enabling lean R&D and safer material selection.

Growth-ready plan Emphasize the small, agile team and scalable cloud-based architecture to reassure prospective customers of rapid deployment, easy integration with existing workflows, and support for expanding datasets as their portfolios grow.